Global Contraceptive Market: Industry Analysis & Outlook (2018-2022) with Profiles for Bayer, Allergan, Merck & Co, and Teva Pharmaceuticals - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Oct 10, 2018--The “Global Contraceptive Market: Industry Analysis & Outlook (2018-2022)” report has been added to ResearchAndMarkets.com’s offering.
The global contraceptive market is experiencing a robust growth at a lucrative CAGR. Every year, a greater number of people undergoing contraceptive sterilization can be observed. Also, there is a high demand of male condoms due to their affordability, availability and higher efficiency to prevent pregnancy and exposure to sexually transmitted diseases (STDs).
Female contraception drug products are major boosters for the growth of the global contraceptive market. There is a continually growing population of females using hormonal contraception. Oral pills and IUDs are the widely used methods of contraception among females. The global female contraception drug market would continue to move forward with a healthy growth rate in future.
Regionally, the U.S. is the major market for contraceptives due to its increasing female population of childbearing age, higher concentration of key companies, higher awareness of contraceptives and STDs infections, and increasing consumption of female condoms. Also, the desirable size of a family in the U.S. is of two children which supports the consumption of contraceptives in the region. Europe also holds a notable share in the global contraceptive market. However, its share can drop to some extent in future due to decreasing female population of reproductive ages.
In terms of competition, the global contraceptive market is highly fragmented with a huge number of companies selling generic products. However, the global female contraceptive drug market is dominated by four companies that.
Growth DriversIncreasing Female Population of Reproductive Ages Growing Disposable Incomes Increasing Urban Population
Key TrendsUnmet Need for Family Planning Pipeline Programs in Development Increasing Use of Female Condoms Increasing Trend of Non-Daily Dosing
ChallengesDecreasing Fertility Rates Irregularities in Sex Education Associated Risks
Key Topics Covered
2. Global Contraceptive Market
3. Regional Contraceptive Market
4. Market Dynamics
6. Company ProfilesBayer AG Allergan PLC Merck & Co. Teva Pharmaceuticals
For more information about this report visit https://www.researchandmarkets.com/research/7856cp/global?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181010005684/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Women’s Health
INDUSTRY KEYWORD: HEALTH OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 10/10/2018 11:25 AM/DISC: 10/10/2018 11:25 AM